Climara 0.06mg/day Patches 4s

Manufacturer BAYER Active Ingredient Estradiol Transdermal Weekly Patch(es tra DYE ole) Pronunciation KLY-mah-rah (for Climara); es-tra-DYE-ol (for Estradiol)
WARNING: Do not use this drug to prevent heart disease or dementia. A study of women taking an estrogen with a progestin showed a raised chance of heart attack, stroke, blood clot, breast cancer, and dementia. The chance of stroke, blood clot, and dementia was also raised when the estrogen was taken alone. Not all products and doses were studied. It is not known if the same effects may happen with this drug.The chance of endometrial cancer may be raised with the use of estrogen alone in patients with a uterus. Use of a progestin along with estrogen may lower the risk. Call your doctor right away if you have unexplained or long-lasting vaginal bleeding.Use this drug for the shortest time needed at the lowest useful dose. Your doctor will talk with you on a regular basis to see if you need to keep taking this drug. @ COMMON USES: It is used to prevent soft, brittle bones (osteoporosis) after menopause.It is used to prevent or lower the signs of the change of life (menopause).It is used to add estrogen to the body when the ovaries have been taken out or do not work the right way.It may be given to you for other reasons. Talk with the doctor.
🏷️
Drug Class
Hormone Replacement Therapy (HRT)
🧬
Pharmacologic Class
Estrogen Receptor Agonist
🀰
Pregnancy Category
Category X
βœ…
FDA Approved
Mar 1995
βš–οΈ
DEA Schedule
Not Controlled

Overview

ℹ️

What is this medicine?

Climara is a skin patch that contains the hormone estradiol, which is a type of estrogen. It's used by women after menopause to help relieve symptoms like hot flashes and night sweats, and to help prevent thinning of the bones (osteoporosis). You apply one patch to your skin once a week, and it slowly releases the hormone into your body.
πŸ“‹

How to Use This Medicine

Proper Use of This Medication

To use this medication correctly, follow your doctor's instructions and read all the information provided. It's essential to use this medication as directed.

Application Instructions

Apply this medication only to your skin, avoiding the mouth, nose, and eyes, as it may cause burning.
Use the medication at the same time every day to maintain a consistent routine.
Before and after applying the medication, wash your hands thoroughly.
Choose a clean, dry, and healthy area of skin on your lower belly or upper buttocks to apply the patch. Rotate the application site with each new patch, avoiding the same site for at least 7 days.
Do not apply the patch to skin with any problems, such as irritation, cuts, or wounds.
Avoid applying the patch to the breast or skin where you have recently used creams, oils, lotions, powder, or other skin products, as this may affect the patch's adhesion.
Select a hair-free area for patch application.
Do not apply the patch to your waistline or an area that may cause the patch to come off when sitting.
Do not cut or divide the patches, and do not use damaged patches.

Managing the Patch

If the patch falls off, reapply it to the same site. If you cannot reapply the patch, apply a new one to a different area.
Wear only one patch at a time.
After removing a used patch, fold the sticky sides together and dispose of it in a secure location, out of reach of children and pets.

Storage and Disposal

Store this medication at room temperature in a dry place, avoiding bathrooms.
Dispose of used patches and packaging in a secure location, following local regulations and guidelines.

Missed Dose

* If you miss a dose, apply a new patch as soon as possible after removing the old one.
πŸ’‘

Lifestyle & Tips

  • Do not smoke: Smoking significantly increases the risk of blood clots, stroke, and heart attack, especially when combined with estrogen therapy.
  • Maintain a healthy weight: Obesity can increase cardiovascular risks.
  • Engage in regular physical activity: Helps maintain bone density and cardiovascular health.
  • Eat a balanced diet: Important for overall health and bone health.
  • Limit alcohol intake: Excessive alcohol can affect liver function and increase certain risks.

Dosing & Administration

πŸ‘¨β€βš•οΈ

Adult Dosing

Standard Dose: Apply one Climara 0.06 mg/day transdermal patch to the lower abdomen or buttocks once weekly. Rotate application sites.
Dose Range: 0.025 - 0.1 mg

Condition-Specific Dosing:

vasomotorSymptomsOfMenopause: Initial dose typically 0.025 mg/day or 0.0375 mg/day, adjusted based on response. The 0.06 mg/day patch is a common maintenance dose.
preventionOfPostmenopausalOsteoporosis: 0.025 mg/day or 0.0375 mg/day, adjusted based on response and bone mineral density. The 0.06 mg/day patch may be used.
πŸ‘Ά

Pediatric Dosing

Neonatal: Not established
Infant: Not established
Child: Not established
Adolescent: Not established
βš•οΈ

Dose Adjustments

Renal Impairment:

Mild: No specific dose adjustment recommended, but use with caution.
Moderate: No specific dose adjustment recommended, but use with caution.
Severe: No specific dose adjustment recommended, but use with caution.
Dialysis: Not studied. Use with caution due to potential for fluid retention and electrolyte imbalance.

Hepatic Impairment:

Mild: Use with caution. Estrogens are extensively metabolized by the liver.
Moderate: Contraindicated in severe hepatic impairment. Use with extreme caution in moderate impairment, consider lower doses or alternative therapies.
Severe: Contraindicated.

Pharmacology

πŸ”¬

Mechanism of Action

Estradiol is the primary estrogen secreted by the human ovary. It binds to and activates nuclear estrogen receptors (ERΞ± and ERΞ²) in target tissues, forming a ligand-receptor complex that interacts with estrogen response elements (EREs) on DNA. This interaction modulates gene transcription, leading to the synthesis of specific proteins responsible for the physiological effects of estrogens, including those on the reproductive system, bone, cardiovascular system, and central nervous system. In the context of menopause, it replaces declining endogenous estrogen levels to alleviate vasomotor symptoms and prevent bone loss.
πŸ“Š

Pharmacokinetics

Absorption:

Bioavailability: High (transdermal bypasses first-pass hepatic metabolism, leading to a more favorable estradiol to estrone ratio compared to oral administration).
Tmax: Steady-state estradiol concentrations are generally achieved within 24-48 hours after patch application and maintained for the 7-day dosing interval.
FoodEffect: Not applicable for transdermal patch.

Distribution:

Vd: Approximately 1.2 L/kg (for estradiol)
ProteinBinding: Highly protein bound (>95%), primarily to sex hormone-binding globulin (SHBG) and albumin.
CnssPenetration: Limited for therapeutic effects, but estrogens do cross the blood-brain barrier and have effects on CNS function.

Elimination:

HalfLife: Estradiol: Approximately 1-2 hours (systemic, but sustained release from patch). Estrone: Approximately 4-5 hours.
Clearance: Not readily quantifiable for transdermal systems due to sustained release.
ExcretionRoute: Primarily renal (urine) as glucuronide and sulfate conjugates; some fecal excretion.
Unchanged: <1% (of estradiol)
⏱️

Pharmacodynamics

OnsetOfAction: Relief of vasomotor symptoms may begin within a few weeks, with full effect typically seen after 4-6 weeks.
PeakEffect: Steady-state concentrations are maintained throughout the 7-day dosing interval.
DurationOfAction: 7 days (due to sustained release from the transdermal patch).

Safety & Warnings

⚠️

BLACK BOX WARNING

Estrogens and Estrogen Plus Progestin Therapies:
1. Cardiovascular Disorders: Estrogen-alone therapy and estrogen plus progestin therapy should not be used for the prevention of cardiovascular disease or dementia. The Women's Health Initiative (WHI) study reported increased risks of stroke and deep vein thrombosis (DVT) in postmenopausal women receiving estrogen-alone therapy. The WHI study reported increased risks of myocardial infarction (MI), stroke, invasive breast cancer, pulmonary embolism (PE), and DVT in postmenopausal women receiving estrogen plus progestin therapy.
2. Endometrial Cancer: The WHI study reported an increased risk of endometrial cancer in postmenopausal women with a uterus who use unopposed estrogen therapy. Adequate diagnostic measures, including directed or random endometrial sampling when indicated, should be undertaken to rule out malignancy in all cases of undiagnosed persistent or recurrent abnormal genital bleeding.
3. Probable Dementia: The WHI Memory Study (WHIMS), a substudy of the WHI, reported an increased risk of probable dementia in postmenopausal women 65 years of age or older receiving estrogen-alone therapy or estrogen plus progestin therapy.
⚠️

Side Effects

Serious Side Effects: Seek Medical Attention Immediately

Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you experience any of the following symptoms, contact your doctor or seek medical help right away:

Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of liver problems, including:
+ Dark urine
+ Tiredness
+ Decreased appetite
+ Upset stomach or stomach pain
+ Light-colored stools
+ Vomiting
+ Yellow skin or eyes
Signs of gallbladder problems, such as:
+ Pain in the upper right belly area, right shoulder area, or between the shoulder blades
+ Yellow skin or eyes
+ Fever with chills
+ Bloating
+ Severe upset stomach or vomiting
Signs of pancreatitis (pancreas problem), including:
+ Severe stomach pain
+ Severe back pain
+ Severe upset stomach or vomiting
Signs of high blood pressure, such as:
+ Severe headache or dizziness
+ Passing out
+ Changes in eyesight
Weakness on one side of the body
Trouble speaking or thinking
Changes in balance
Drooping on one side of the face
Blurred eyesight
Eyesight changes or loss
Bulging eyes
Changes in how contact lenses feel
Breast changes, including:
+ Lump in the breast
+ Breast pain or soreness
+ Nipple discharge
Vaginal changes, including:
+ Itching or discharge
+ Abnormal vaginal bleeding
Depression or other mood changes
Memory problems or loss
Fever
Urination problems, including:
+ Inability to pass urine
+ Changes in urine output
+ Pain when passing urine
Swelling or fluid retention in the body, including:
+ Weight gain
+ Trouble breathing
Signs of a blood clot, such as:
+ Chest pain or pressure
+ Coughing up blood
+ Shortness of breath
+ Swelling, warmth, numbness, changes in color, or pain in a leg or arm
+ Trouble speaking or swallowing
High calcium levels, which can cause:
+ Weakness
+ Confusion
+ Fatigue
+ Headache
+ Upset stomach or vomiting
+ Constipation
+ Bone pain

Other Possible Side Effects

Most people do not experience serious side effects, and many have only minor or no side effects at all. However, if you experience any of the following side effects, contact your doctor or seek medical help if they bother you or do not go away:

Dizziness or headache
Hair loss
Upset stomach or vomiting
Constipation
Stomach pain or cramps
Bloating
Enlarged or tender breasts
Vaginal bleeding or spotting
Painful periods
Signs of a common cold
Nose or throat irritation
Weight gain or loss
Joint pain
Leg cramps
Changes in sex interest
Irritation at the site of administration

This is not a comprehensive list of all possible side effects. If you have questions or concerns about side effects, contact your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • Sudden, severe headache
  • Sudden vision changes (e.g., partial or complete loss of vision)
  • Sudden numbness or weakness in your arm, leg, or face, especially on one side of the body
  • Trouble speaking or understanding speech
  • Sudden chest pain, shortness of breath, or coughing up blood
  • Pain, swelling, or warmth in your leg (especially calf)
  • Yellowing of your skin or eyes (jaundice)
  • Severe abdominal pain
  • New breast lump or changes in existing breast lumps
  • Unusual vaginal bleeding (e.g., bleeding after menopause, heavy bleeding, or bleeding between periods if you still have your uterus and are taking progestin)
πŸ“‹

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following:

Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Be sure to describe the allergic reaction you experienced, including any symptoms that occurred.
A history of certain health conditions, including:
+ Bleeding disorders
+ Blood clots or an increased risk of blood clots
+ Breast cancer
+ Liver problems or liver tumors
+ Heart attack or stroke
+ Tumors that are sensitive to estrogen
Any instances of unexplained vaginal bleeding
If you are pregnant or think you might be pregnant. Do not take this medication if you are pregnant.

This list is not exhaustive, and it is crucial to discuss all your medications (prescription, over-the-counter, natural products, and vitamins) and health issues with your doctor and pharmacist. They will help determine if it is safe to take this medication with your other medications and health conditions. Never start, stop, or adjust the dosage of any medication without first consulting your doctor.
⚠️

Precautions & Cautions

It is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication. Your doctor may advise you to stop taking this drug before certain surgical procedures, and will provide guidance on when to resume taking it after the surgery or procedure.

If you will be immobile for extended periods, such as during long trips, bedrest after surgery, or illness, discuss this with your doctor, as prolonged immobility may increase your risk of developing blood clots. If you have diabetes, it is crucial to closely monitor your blood sugar levels.

Be aware that medications like this one can cause high blood pressure. Follow your doctor's instructions for regular blood pressure checks. Additionally, have your blood work and bone density checked as directed by your doctor.

Regular breast exams and gynecology check-ups are vital, and you should also perform breast self-exams as instructed by your doctor. The risk of certain side effects, such as heart attack, stroke, breast cancer, and ovarian cancer, may vary depending on factors like the duration of estrogen use, whether it is taken with or without a progestin, and other individual factors. Discuss the benefits and risks of using this medication with your doctor.

High triglyceride levels have been associated with this drug. If you have a history of high triglyceride levels, inform your doctor. This medication may cause dark skin patches on your face, so it is essential to avoid sun exposure, sunlamps, and tanning beds, and use sunscreen and protective clothing and eyewear when going outside.

This drug may interfere with certain laboratory tests, so inform all your healthcare providers and lab personnel that you are taking this medication. Avoid smoking, as it increases the risk of heart disease, and limit your alcohol consumption. If you regularly consume grapefruit juice or eat grapefruit, discuss this with your doctor.

For optimal effectiveness, use this medication in conjunction with calcium and vitamin D supplements and engage in weight-bearing exercises like walking or physical therapy. Follow the diet and exercise plan recommended by your doctor.

In some cases, this medication may affect growth in children and teenagers, so regular growth checks may be necessary. Discuss this with your doctor. If you are 65 or older, use this medication with caution, as you may be more susceptible to side effects. If you are breastfeeding, consult your doctor to discuss potential risks to your baby.
πŸ†˜

Overdose Information

Overdose Symptoms:

  • Nausea
  • Vomiting
  • Breast tenderness
  • Abdominal pain
  • Drowsiness/fatigue
  • Withdrawal bleeding (in females)

What to Do:

Remove the patch immediately. Seek medical attention. There is no specific antidote. Treatment is symptomatic and supportive. Call 911 or your local poison control center (e.g., 1-800-222-1222 in the US).

Drug Interactions

πŸ”΄

Major Interactions

  • CYP3A4 Inducers (e.g., Carbamazepine, Phenobarbital, Phenytoin, Rifampin, St. John's Wort): May significantly decrease estradiol plasma concentrations, leading to reduced therapeutic effect and potential for breakthrough bleeding.
  • Aromatase Inhibitors (e.g., Anastrozole, Letrozole, Exemestane): Estrogens are contraindicated with aromatase inhibitors as they counteract their mechanism of action in breast cancer treatment.
🟑

Moderate Interactions

  • CYP3A4 Inhibitors (e.g., Ketoconazole, Itraconazole, Ritonavir, Clarithromycin, Grapefruit Juice): May increase estradiol plasma concentrations, potentially leading to increased adverse effects.
  • Thyroid Hormone Replacement Therapy (e.g., Levothyroxine): Estrogens can increase thyroid-binding globulin (TBG) levels, leading to a decrease in free thyroid hormone. Patients on thyroid replacement therapy may require an increased dose of thyroid hormone.
  • Corticosteroids (e.g., Prednisolone): Estrogens may decrease the clearance of corticosteroids, leading to increased corticosteroid effects and toxicity.
  • Anticoagulants (e.g., Warfarin): Estrogens may diminish the anticoagulant effect of warfarin. Close monitoring of INR is recommended.
  • Lamotrigine: Estrogens may decrease lamotrigine plasma concentrations, potentially leading to loss of seizure control.
🟒

Minor Interactions

  • Folic Acid: Estrogens may increase the need for folic acid.
  • Vitamin B6: Estrogens may increase the need for vitamin B6.

Monitoring

πŸ”¬

Baseline Monitoring

Complete Medical History and Physical Examination

Rationale: To identify contraindications, risk factors for cardiovascular disease, breast cancer, and other conditions.

Timing: Prior to initiation of therapy.

Blood Pressure

Rationale: Estrogens can affect blood pressure.

Timing: Prior to initiation.

Breast Examination and Mammography

Rationale: To screen for breast cancer, as estrogens may increase risk.

Timing: Prior to initiation, according to age-appropriate guidelines.

Pelvic Examination and Pap Smear

Rationale: To screen for gynecological conditions, including endometrial hyperplasia/cancer (if uterus intact).

Timing: Prior to initiation, according to age-appropriate guidelines.

Lipid Profile (Total Cholesterol, HDL, LDL, Triglycerides)

Rationale: Estrogens can affect lipid metabolism.

Timing: Prior to initiation, if clinically indicated.

Liver Function Tests (LFTs)

Rationale: Estrogens are metabolized by the liver; baseline assessment is important, especially in patients with hepatic impairment.

Timing: Prior to initiation, if clinically indicated.

πŸ“Š

Routine Monitoring

Annual Physical Examination

Frequency: Annually

Target: N/A

Action Threshold: N/A

Blood Pressure

Frequency: Annually, or more frequently if clinically indicated.

Target: Normal range for age and comorbidities.

Action Threshold: Sustained elevation (e.g., >140/90 mmHg) requires evaluation and management.

Breast Examination and Mammography

Frequency: Annually for breast exam; mammography according to age-appropriate guidelines (e.g., every 1-2 years).

Target: N/A

Action Threshold: Any new lump, discharge, or suspicious finding requires immediate investigation.

Pelvic Examination and Pap Smear

Frequency: Annually for pelvic exam; Pap smear according to current screening guidelines.

Target: N/A

Action Threshold: Abnormal bleeding, pain, or suspicious findings require investigation.

Symptoms of Endometrial Hyperplasia/Cancer (if uterus intact)

Frequency: Ongoing patient education and inquiry at each visit.

Target: Absence of abnormal uterine bleeding.

Action Threshold: Any abnormal or unscheduled vaginal bleeding requires prompt investigation to rule out endometrial pathology.

Symptoms of Thromboembolic Events (DVT, PE, Stroke, MI)

Frequency: Ongoing patient education and inquiry at each visit.

Target: Absence of symptoms.

Action Threshold: New onset of chest pain, shortness of breath, leg swelling/pain, sudden severe headache, visual disturbances, or neurological deficits requires immediate medical attention.

πŸ‘οΈ

Symptom Monitoring

  • Abnormal vaginal bleeding (spotting, breakthrough bleeding, prolonged bleeding)
  • Breast lumps or tenderness
  • Swelling, pain, or redness in a leg (DVT symptoms)
  • Sudden chest pain, shortness of breath, coughing up blood (PE symptoms)
  • Sudden severe headache, vision changes, slurred speech, weakness/numbness on one side of the body (Stroke symptoms)
  • Chest pain, discomfort, shortness of breath, pain radiating to arm/jaw (MI symptoms)
  • Jaundice or yellowing of skin/eyes
  • Severe abdominal pain
  • Mood changes, depression

Special Patient Groups

🀰

Pregnancy

Climara is contraindicated during pregnancy. There is no indication for estrogen therapy in pregnancy. Estrogen exposure during pregnancy has been associated with an increased risk of birth defects in the reproductive organs of female fetuses.

Trimester-Specific Risks:

First Trimester: Potential for adverse effects on fetal development, particularly reproductive organs.
Second Trimester: Not indicated; continued exposure is not recommended.
Third Trimester: Not indicated; continued exposure is not recommended.
🀱

Lactation

Climara is not recommended during lactation. Estrogens are excreted in human milk and may decrease the quantity and quality of breast milk. Potential adverse effects on the nursing infant are unknown but generally considered undesirable.

Infant Risk: L4 (Possibly Hazardous) - Estrogens can pass into breast milk and may affect the infant, though specific risks are not well-defined. They can also reduce milk supply.
πŸ‘Ά

Pediatric Use

Climara is not indicated for use in pediatric patients. Safety and efficacy have not been established in this population. Estrogen therapy in children could affect bone maturation and pubertal development.

πŸ‘΄

Geriatric Use

Use with caution in women 65 years of age or older. The WHIMS study showed an increased risk of probable dementia in women 65 years of age or older receiving estrogen-alone or estrogen plus progestin therapy. Consider the lowest effective dose for the shortest duration consistent with treatment goals. Closely monitor for adverse events, particularly cardiovascular and cognitive effects.

Clinical Information

πŸ’Ž

Clinical Pearls

  • Transdermal estradiol bypasses first-pass hepatic metabolism, resulting in a more favorable estradiol-to-estrone ratio and potentially lower risk of certain adverse effects (e.g., VTE) compared to oral estrogens, though risks still exist.
  • Always assess for the presence of a uterus. If the patient has an intact uterus, a progestin must be co-administered with estrogen to reduce the risk of endometrial hyperplasia and cancer.
  • Rotate application sites weekly to avoid skin irritation. Apply to a clean, dry area on the lower abdomen or buttocks, avoiding the waistline, breasts, or irritated skin.
  • The lowest effective dose for the shortest duration consistent with treatment goals should be used for menopausal hormone therapy.
  • Regular monitoring, including annual physical exams, breast exams, and mammograms, is crucial.
  • Educate patients thoroughly on the Black Box Warnings, especially regarding cardiovascular risks and the importance of reporting any unusual symptoms immediately.
πŸ”„

Alternative Therapies

  • Other transdermal estradiol patches (e.g., Vivelle-Dot, Minivelle, Dotti)
  • Oral estrogens (e.g., Estrace, Premarin)
  • Vaginal rings (e.g., Estring, Femring)
  • Estrogen gels/sprays (e.g., Divigel, Elestrin, Evamist)
  • Non-hormonal therapies for vasomotor symptoms (e.g., SSRIs/SNRIs like paroxetine, venlafaxine; gabapentin; clonidine)
  • Bisphosphonates or other anti-resorptive agents for osteoporosis prevention/treatment (if HRT is contraindicated or not preferred for bone health)
πŸ’°

Cost & Coverage

Average Cost: Varies, typically $100-$300+ per 4 patches (1 month supply)
Generic Available: Yes
Insurance Coverage: Tier 2 or 3 (for brand name); Tier 1 (for generic)
πŸ“š

General Drug Facts

If your symptoms or health issues persist or worsen, it is essential to contact your doctor for further guidance. To ensure your safety, never share your medication with others or take someone else's medication. Some medications may come with an additional patient information leaflet, so it's a good idea to check with your pharmacist. If you have any questions or concerns about this medication, don't hesitate to discuss them with your doctor, nurse, pharmacist, or other healthcare provider. In the event of a suspected overdose, immediately call your local poison control center or seek emergency medical attention. When reporting the incident, be prepared to provide details about the medication taken, the amount, and the time it occurred.